Xiang Yi
Xiang Yi
Verified email at
Cited by
Cited by
Novel nanomaterials for clinical neuroscience
JL Gilmore, X Yi, L Quan, AV Kabanov
Journal of NeuroImmune Pharmacology 3 (2), 83-94, 2008
Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors
W Hu, Z Guo, F Chu, A Bai, X Yi, G Cheng, J Li
Bioorganic & medicinal chemistry 11 (7), 1153-1160, 2003
Agile delivery of protein therapeutics to CNS
X Yi, DS Manickam, A Brynskikh, AV Kabanov
Journal of Controlled Release 190, 637-663, 2014
Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly (2-oxazoline) s nanoformulation
J Tong, MC Zimmerman, S Li, X Yi, R Luxenhofer, R Jordan, AV Kabanov
Biomaterials 32 (14), 3654-3665, 2011
Transport across the blood-brain barrier of pluronic leptin
TO Price, SA Farr, X Yi, S Vinogradov, E Batrakova, WA Banks, ...
Journal of Pharmacology and Experimental Therapeutics 333 (1), 253-263, 2010
Protein modification with amphiphilic block copoly (2-oxazoline) s as a new platform for enhanced cellular delivery
J Tong, R Luxenhofer, X Yi, R Jordan, AV Kabanov
Molecular pharmaceutics 7 (4), 984-992, 2010
Conjugates of superoxide dismutase 1 with amphiphilic poly (2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and …
J Tong, X Yi, R Luxenhofer, WA Banks, R Jordan, MC Zimmerman, ...
Molecular pharmaceutics 10 (1), 360-377, 2013
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery
NM Harris, R Ritzel, NS Mancini, Y Jiang, X Yi, DS Manickam, WA Banks, ...
Pharmacology Biochemistry and Behavior 150, 48-56, 2016
Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin
JA Falcone, TS Salameh, X Yi, BJ Cordy, WG Mortell, AV Kabanov, ...
Journal of Pharmacology and Experimental Therapeutics 351 (1), 54-60, 2014
Small-sized mPEG–PLGA nanoparticles of Schisantherin A with sustained release for enhanced brain uptake and anti-parkinsonian activity
T Chen, C Li, Y Li, X Yi, R Wang, SMY Lee, Y Zheng
ACS applied materials & interfaces 9 (11), 9516-9527, 2017
Discovery of 2-Phenyl-3-sulfonylphenyl-indole derivatives as a new class of selective COX-2 inhibitors
W Hu, Z Guo, X Yi, C Guo, F Chu, G Cheng
Bioorganic & medicinal chemistry 11 (24), 5539-5544, 2003
Nanoformulation of brain‐derived neurotrophic factor with target receptor‐triggered‐release in the central nervous system
Y Jiang, JM Fay, CD Poon, N Vinod, Y Zhao, K Bullock, S Qin, ...
Advanced functional materials 28 (6), 1703982, 2018
Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier
Y Li, T Chen, X Miao, X Yi, X Wang, H Zhao, SMY Lee, Y Zheng
Pharmacological research 125, 246-257, 2017
Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons
X Yi, MC Zimmerman, R Yang, J Tong, S Vinogradov, AV Kabanov
Free Radical Biology and Medicine 49 (4), 548-558, 2010
Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery
X Yi, E Batrakova, WA Banks, S Vinogradov, AV Kabanov
Bioconjugate chemistry 19 (5), 1071-1077, 2008
Oral delivery of a nanocrystal formulation of schisantherin a with improved bioavailability and brain delivery for the treatment of Parkinson’s disease
T Chen, C Li, Y Li, X Yi, SMY Lee, Y Zheng
Molecular pharmaceutics 13 (11), 3864-3875, 2016
Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity
X Yi, D Yuan, SA Farr, WA Banks, CD Poon, AV Kabanov
Journal of Controlled Release 191, 34-46, 2014
Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers
Y Li, X Miao, T Chen, X Yi, R Wang, H Zhao, SMY Lee, X Wang, Y Zheng
Colloids and Surfaces B: Biointerfaces 156, 227-235, 2017
Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors
X Yi, Z Guo, FM Chu
Bioorganic & medicinal chemistry 11 (7), 1465-1474, 2003
Pluronic P85/F68 micelles of baicalein could interfere with mitochondria to overcome MRP2-mediated efflux and offer improved anti-Parkinsonian activity
T Chen, Y Li, C Li, X Yi, R Wang, SMY Lee, Y Zheng
Molecular Pharmaceutics 14 (10), 3331-3342, 2017
The system can't perform the operation now. Try again later.
Articles 1–20